0001567619-20-015832.txt : 20200820 0001567619-20-015832.hdr.sgml : 20200820 20200820170100 ACCESSION NUMBER: 0001567619-20-015832 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200818 FILED AS OF DATE: 20200820 DATE AS OF CHANGE: 20200820 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MCKEON BRIAN P CENTRAL INDEX KEY: 0001219445 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19271 FILM NUMBER: 201120698 MAIL ADDRESS: STREET 1: IDEXX LABORATORIES STREET 2: ONE IDEXX DRIVE CITY: WESTBROOK STATE: ME ZIP: 04092 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IDEXX LABORATORIES INC /DE CENTRAL INDEX KEY: 0000874716 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 010393723 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE IDEXX DRIVE CITY: WESTBROOK STATE: ME ZIP: 04092-2041 BUSINESS PHONE: 2075560300 MAIL ADDRESS: STREET 1: ONE IDEXX DRIVE CITY: WESTBROOK STATE: ME ZIP: 04092-2041 FORMER COMPANY: FORMER CONFORMED NAME: IDEXX CORP / DE DATE OF NAME CHANGE: 19600201 4 1 doc1.xml FORM 4 X0306 4 2020-08-18 0 0000874716 IDEXX LABORATORIES INC /DE IDXX 0001219445 MCKEON BRIAN P ONE IDEXX DRIVE WESTBROOK ME 04092 0 1 0 0 Executive VP & CFO Common Stock 2020-08-18 4 M 0 1880 53.185 A 51486 D Common Stock 2020-08-18 4 M 0 1256 79.54 A 52732 D Incentive Stock Option (right-to-buy) 53.185 2020-08-18 4 M 0 1880 D 2023-12-31 Common Stock 1880 0 D Incentive Stock Option (right-to-buy) 79.54 2020-08-18 4 M 0 1256 D 2025-02-13 Common Stock 1256 0 D Grant of option to buy 4,700 shares of Issuer common stock that vested in five annual installments beginning on January 1, 2015. The number of derivative securities reported as beneficially owned and price with respect to this option were adjusted to reflect a 2-for-1 stock split in the form of a 100% stock dividend on IDEXX Laboratories, Inc. common stock paid on June 15, 2015 (the "Stock Split"). Grant of option to buy 628 shares of Issuer common stock that vested on February 14, 2020. The number of derivative securities reported as beneficially owned and price with respect to this option were adjusted to reflect the Stock Split. Not applicable. /s/ Lily J. Lu, Attorney-in-Fact for Brian P. McKeon 2020-08-20